BSX FY 2018 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

FY 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$9.8B+8.6% YoY

Gross Profit

$6.5B65.9% margin

Operating Income

$1.7B17.7% margin

Net Income

$1.7B17.0% margin

EPS (Diluted)

$1.19

Cash Flow

Operating Cash Flow

$310M

Free Cash Flow

-$6M

Stock-Based Comp.

$140M

Balance Sheet

Total Assets

$21.0B

Total Liabilities

$12.3B

Stockholders' Equity

$8.7B

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9.8B	$9.0B	+8.6%
Gross Profit	$6.5B	$5.9B	+10.3%
Operating Income	$1.7B	$1.5B	+13.9%
Net Income	$1.7B	$104M	+1506.7%